Zhen Zhang

From detection to action: ctDNA-MRD surveillance and translational strategies in early breast cancer

Recurrence remains a major cause of mortality in early breast cancer (EBC), and conventional follow-up often identifies relapse only after clinically detectable disease has emerged. Circulating tumor DNA–based minimal residual disease (ctDNA-MRD) testing offers the possibility of detecting molecular relapse earlier and...